PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 112 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,377,021 | -27.6% | 422,085 | 0.0% | 0.98% | -12.8% |
| Q2 2023 | $6,044,257 | +100.6% | 422,085 | 0.0% | 1.12% | +99.6% |
| Q1 2023 | $3,013,687 | -36.4% | 422,085 | 0.0% | 0.56% | -9.4% |
| Q4 2022 | $4,735,794 | +1.3% | 422,085 | 0.0% | 0.62% | -7.1% |
| Q3 2022 | $4,677,000 | +31.3% | 422,085 | 0.0% | 0.66% | +74.5% |
| Q2 2022 | $3,562,000 | -38.0% | 422,085 | 0.0% | 0.38% | -11.0% |
| Q1 2022 | $5,745,000 | -30.8% | 422,085 | 0.0% | 0.43% | -9.5% |
| Q4 2021 | $8,302,000 | -38.7% | 422,085 | 0.0% | 0.47% | -46.1% |
| Q3 2021 | $13,549,000 | – | 422,085 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $68,694,000 | 39.92% |
| Greenspring Associates, LLC | 360,939 | $11,990,000 | 15.57% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $193,587,000 | 14.91% |
| Abingworth LLP | 1,203,135 | $39,956,000 | 13.67% |
| Penn Mutual Asset Management | 86,940 | $2,888,000 | 2.55% |
| RA Capital Management | 3,825,008 | $127,067,000 | 1.78% |
| LUMINUS MANAGEMENT LLC | 126,903 | $4,216,000 | 0.98% |
| Pinz Capital Management, LP | 33,600 | $1,116,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 175,000 | $5,814,000 | 0.47% |
| Summit Rock Advisors, LP | 34,350 | $1,141,000 | 0.40% |